Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZBTB44-DT is a long non-coding RNA (lncRNA) transcribed divergently from the ZBTB44 locus. Such divergent transcripts often function as cis-regulatory elements, influencing the expression of the protein-coding gene nearby. There is no evidence that ZBTB44-DT encodes a protein, nor that it serves as a direct therapeutic target. It is mainly of interest as a potential regulatory RNA that may modulate local chromatin state or transcriptional activity of ZBTB44[5][4]. ZBTB44-DT is not a receptor, enzyme, or other classic drug target, but rather a non-coding RNA, likely functioning in genomic regulation. No disease associations, drug interactions, or clinical biomarker roles are described in the current literature[5][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZBTB44 divergent transcript (ZBTB44-DT).